Telehealth Exercise Training in Peripheral Arterial Disease - TEXT-PAD
NCT ID: NCT05260567
Last Updated: 2023-11-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2022-02-05
2023-11-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This is a single-centre randomised control trial in 60 patients with peripheral arterial disease attending the Freeman Hospital. Patients will be randomised to either an enhanced behavioural change intervention targeting multiple health behaviours vs a simple walking intervention. Also, some patients will be involved in focus groups to understand their experience of the intervention and whether it is feasible and acceptable, allowing changes to be made to the program.
The primary outcome will be to assess the feasibility and acceptability of the program. We will also be assessing multiple secondary outcomes including functional capacity, quality of life, sleep quality and smoking and alcohol reduction.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease
NCT06033924
Physical Activity Daily - An Internet-Based Walking Program for Patients With Peripheral Arterial Disease
NCT02022423
Effectiveness of Group Walking Sessions for Increasing Activity in People With Peripheral Arterial Disease (The Group Oriented Arterial Leg Study [GOALS])
NCT00693940
Trial of a New Online Programme for Physical Activity and Healthy Eating.
NCT03032731
Motivational Interviewing (MI) for African Americans With Peripheral Arterial Disease (PAD) Pilot
NCT01332058
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise and Lifestyle Change
Exercise training and lifestyle change
Exercise and Lifestyle Change
Patients will undergo to weekly phone call/videoconference for 12 weeks and discuss the behaviour change.
They also will undergo to home-based exercise training will be performed twice a week for 12 weeks via Zoom (up to 5 patients per session). Each session will be comprised of warm-up (10 min), the main part (15 to 20 min), and cooldown (5 to 10 min). The training aims to develop resistance, aerobic and functional capacity such as getting up, walking, pulling, pushing, throwing, transferring body weight or external loads. In addition, patients will be encouraged to increase their physical activity. Patients will be provided with a Fitbit device to monitor their step count and will be recommended to increase their previous week's average step count by 10%.
Standard Care
Patients will also receive specific advice to perform an unsupervised walking exercise according to NICE guideline.
Exercise and Lifestyle Change
Patients will undergo to weekly phone call/videoconference for 12 weeks and discuss the behaviour change.
They also will undergo to home-based exercise training will be performed twice a week for 12 weeks via Zoom (up to 5 patients per session). Each session will be comprised of warm-up (10 min), the main part (15 to 20 min), and cooldown (5 to 10 min). The training aims to develop resistance, aerobic and functional capacity such as getting up, walking, pulling, pushing, throwing, transferring body weight or external loads. In addition, patients will be encouraged to increase their physical activity. Patients will be provided with a Fitbit device to monitor their step count and will be recommended to increase their previous week's average step count by 10%.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise and Lifestyle Change
Patients will undergo to weekly phone call/videoconference for 12 weeks and discuss the behaviour change.
They also will undergo to home-based exercise training will be performed twice a week for 12 weeks via Zoom (up to 5 patients per session). Each session will be comprised of warm-up (10 min), the main part (15 to 20 min), and cooldown (5 to 10 min). The training aims to develop resistance, aerobic and functional capacity such as getting up, walking, pulling, pushing, throwing, transferring body weight or external loads. In addition, patients will be encouraged to increase their physical activity. Patients will be provided with a Fitbit device to monitor their step count and will be recommended to increase their previous week's average step count by 10%.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \>= 40 years
* Able to walk distance \>50m
* Live in an area deemed in lowest 30% of super output area from Office of National Statistics
Exclusion Criteria
* short claudication distance \<50m
* severe heart disease (Grade III or IV, New York Heart Association)
* severe ischemic or haemorrhagic stroke or neurodegenerative diseases
* severe hypertension (systolic blood pressure of more than 180 mm Hg, and a diastolic
* blood pressure of more than 100 mm Hg)
* uncontrolled cardiac arrhythmias (unstable angina during the previous month and
* myocardial infarction during the previous month)
* a resting heart rate of more than 120 beats per minute
* has already undergone angioplasty, bypass or other surgical intervention for PAD
* other severe comorbid conditions preventing the ability to engage in physical activity,
* inability or unwillingness to undertake the commitments of the study
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northumbria University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gabriel Cucato
Vice Chancellor Research Fellow
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James Prentis
Role: PRINCIPAL_INVESTIGATOR
Freeman Hospital - Newcastle upon Tyne NHS trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Freeman Hospital - Newcastle upon Tyne NHS trust
Newcastle upon Tyne, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
286735
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.